Difference between revisions of "SPECT Biomarker Ctte"
Jump to navigation
Jump to search
(Created page with "==Project Snapshot== The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging. Under consideration: *quantifying a small structure (l...") |
|||
| Line 22: | Line 22: | ||
==Reference Materials== | ==Reference Materials== | ||
| + | |||
| + | *[[Media:System Variance Model for SPECT Ioflupane.pdf | System Variance Model for SPECT Ioflupane - Drs. Smith and Zeintl (Siemens)]] ''November 20, 2015'' | ||
| + | |||
| + | |||
| + | |||
03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg: | 03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg: | ||
The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A | The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A | ||
Revision as of 00:07, 21 November 2015
Project Snapshot
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.
Under consideration:
- quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
- quantifying organs, like the liver, for dosimetry as potential use cases
Meetings/Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Reference Materials
03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A